Peptides for Muscle Growth Research: What Studies Show About Growth-Promoting Peptides
A research-focused review of peptides associated with muscle growth, including CJC-1295, Ipamorelin, IGF-1 LR3, and HGH fragment peptides — what the studies show and what they don't.
Why Peptides Are Studied for Muscle Growth
Many peptides act on or near the growth hormone (GH) / IGF-1 axis — the primary biological pathway governing muscle protein synthesis and lean mass accumulation. Researchers study these compounds to understand how targeted manipulation of this axis might differ from direct growth hormone administration.
Growth Hormone Secretagogues (GHS)
These peptides stimulate the pituitary gland to produce and release growth hormone rather than delivering GH directly.
CJC-1295
CJC-1295 is a GHRH (Growth Hormone Releasing Hormone) analogue. Research has focused on its extended half-life compared to endogenous GHRH. Clinical studies in healthy adults showed dose-dependent increases in GH and IGF-1 levels with sustained release profiles.
Ipamorelin
Ipamorelin is a selective GHRP (Growth Hormone Releasing Peptide). Research highlights include:
- High GH selectivity with minimal cortisol and prolactin effects
- Dose-dependent GH pulse augmentation in animal and human studies
- Generally considered one of the cleaner GHRP options in research
IGF-1 and Its Analogues
IGF-1 LR3
IGF-1 LR3 is a modified form of Insulin-like Growth Factor 1 with an extended half-life. Unlike endogenous IGF-1, which binds quickly to IGF-binding proteins, LR3 has reduced binding protein affinity.
What the Evidence Does and Doesn't Support